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Acute undiﬀentiated leukemia (AUL) is an acute leukemia with no more than one membrane marker of any given lineage.
Blasts often express HLA-DR, CD34, and/or CD38 and may be positive for terminal deoxynucleotidyl transferase (TdT). The
expression of CD34, HLA-DR, and CD38 has been shown in pro-T-ALL, although in this case, blasts should also express
CD7 and cyCD3. However, some cases of T-ALL without CD3 in the cytoplasm and all TCR chain genes in germ line
conﬁguration are reported, features that ﬁt well with a very early hematopoietic cell. We report a case of acute leukemia
CD34+/−HLADR+CD7+CD38+cyCD3− in which a diagnosis of AUL was considered. However the blasts were also positive for
CD99 and TCR delta gene rearrangement which was found on molecular studies. Therefore a diﬀerential diagnosis between AUL
and an early cyCD3 negative T-ALL was debated.
1.Introduction
The distinction between Acute Undiﬀerentiated Leukemia
(AUL) and early Acute Lymphoblastic Leukemia (ALL) is
complex and aﬀects patient management options. AUL is an
acute leukemia with no more than one membrane marker
of any given lineage. It speciﬁcally lacks the T or myeloid
lineage speciﬁc markers cyCD3 and MPO, respectively, and
d o e sn o te x p r e s sB - l i n e a g es p e c i ﬁ cm a r k e r ss u c ha sc y C D 2 2 ,
cyCD79a, or CD19. The tumor also lacks speciﬁc features
of other hematopoietic lineages such as megakaryocytes or
plasmacytoid dendritic cells. Blasts often express HLA-DR,
CD34, and/or CD38 and may be positive for terminal
deoxynucleotidyl transferase (TdT). The blasts are negative
for myeloperoxidase and esterase [1]. The expression of
CD34, HLA-DR, and CD38 has been shown in pro-T-ALL,
although in this case, blasts should also express CD7 and
cyCD3 (Table 1)[ 2]. However, some cases of T-ALL without
CD3 in the cytoplasm and all TCR chain genes in germ line
conﬁguration are reported, features that ﬁt well with a very
early hematopoietic cell [3, 4]. We report a case of acute
leukemia where a diﬀerential diagnosis between an early
cyCD3-T-ALL and an AUL was debated.
2. Case Presentation
A65-year-oldmanwasadmittedtothehospitalinNovember
2008 with a few weeks history of dyspnea and purpura
with edema of the lower left limb. A complete blood count
revealed: White Blood Count 1,8 × 109/l, Hemoglobin 9g/dL,
and Platelet Count 10 × 109/l. Manual diﬀerential showed
6%neutrophils,66%lymphocytes,and28%undiﬀerentiated
blasts with nucleoli and intensely basophilic cytoplasm.
Splenomegalyandlymphadenopathywerepresent.Increased
values of lactic dehydrogenase (LDH) (4.480IU/l, n.v. 250–
450) were registered. The bone marrow aspirate was hyper-
cellularwithblastsofmedium-largesize,withnucleoli,with-
outcytoplasmicgranules,andwithoccasional“handmirror”
forms (Figure 1). Cytochemical assays showed negativity for
myeloperoxidase and α-naphthyl-acetate esterase and 20–
30% of blasts to be PAS positive. Immunohistochemistry
performed on the biopsy core showed that the tumor cells2 Case Reports in Hematology
Table 1: T-ALL EGIL classiﬁcation of T lineage acute lymphoblastic leukemia (T-ALL) modiﬁed by Szczepanski et al. [2].
MARKERS Pro-T-ALL
(EGIL T-I)
Immature thymocyte
(EGIL T-II)
Common
thymocytic T-ALL
mCD3-(Cortical
T-ALL, EGIL T-III)
Common
thymocytic T-ALL
mCD3+ (Cortical
T-ALL, EGIL T-III)
Mature T-ALL
(EGIL T-IV)
T d T+ + + + + ++ ++ +
HLA-DR + −− − −
CD34 + −− − −
CD1a −− ++ ++ −
CD2 + ++ ++ ++ ++
c y C D 3 + + + + + ++ ++ +
CD5 − ++ ++ ++ ++
C D 7+ + + + + ++ ++ +
CD4−CD8− ++ + −−−
CD4+CD8−− +/− +/− +/− +
CD4−CD8+ − +/− +/− +/− +/−
CD4+CD8+ −−++ + / −
mCD3 −−− ++ ++
TcRαβ −−− 60–70% 60–70%
TcRγδ −−− 30–40% 30–40%
<10% of the leukaemias are positive; +/−: 10–25% of the leukaemias are positive; +: 25–75% of the leukaemias are positive; ++: >75% of the leukaemias are
positive.
were CD79a-PAX5-CD68-MPO-CD3-CD7+CD34−. These
results supported the diagnosis of leukocytosis of uncertain
histologic origin. Flow cytometry was carried out by means
of a FacsCanto II cytometer (Becton Dickinson) and samples
were stained with ﬂuorochrome-conjugated monoclonal
antibodies (FITC, PE, PerCP, PE-Cy7, APC, and APC-
Cy7) to the following antigens: CD3, cyCD3, CD2, CD7,
C D 1 a ,C D 4 ,C D 8 ,C D 5 ,C D 1 6 - 5 6 ,T C R αβ,T C R γδ, CD19,
CD20, CD22, CD23, FMC7, CD10, CD38, CD45, K and
λ immunoglobulin light chains, cyCD22, cyCD79a, CD34,
CD99, HLA-DR, CD117, CD33, CD13, MPO, CD45RA, and
CD45RO. Data were collected and analyzed by FacsDiva
software (Becton Dickinson). The blasts were positive for
CD34+/−HLA-DR, CD7, CD99, CD38 (Figure 2), CD45RA,
CD10+/−, and CD4 (not shown). Conventional cytogenetics
performed on the bone marrow revealed a 47, XY karyotype
with trisomy of chromosome 8 (47, XY, +8). T-cell receptor
(TCR) delta gene rearrangements studies by polymerase
chain reaction (PCR) showed the presence of a clonal TCR
rearrangement and therefore a clonal T-cell population.
3. Discussion
The expression of CD34, HLA-DR, and CD7 has been shown
in pro-T-ALL, although in this case, blasts should also
express cyCD3 (Table 1)[ 2]. In AUL, blasts often express
HLA-DR, CD34, and/or CD38 (1). In this case report the
blasts were CD34+/−HLA-DR+CD7+CD38+cyCD3− such
that a diagnosis of AUL was considered. However the
blasts were also positive for CD99 and a TCR delta gene
rearrangement, which was obtained from molecular studies.
Figure 1:Blastsappearofmediumlargesize,withnucleoli,without
cytoplasmic granules.
Thus, a diﬀerential diagnosis between an AUL and early
cyCD3 negative T-ALL was considered.
Nishi et al. reported some cases of c-kit+ T-ALL without
CD3 in the cytoplasm, and all TCR chain genes in germ
line conﬁguration, features that ﬁt well with a very early
hematopoietic cell [3]. Quintanilla-Martinez et al. also
reported three cases of prethymic lymphoblastic lymphoma
which resulted TdT+, HLA-DR+, CD34+, CD71+, CD38+,
and CD7+, most resembling the normal prothymocyte.
The prethymic T-cell character was further supported by
germline T-cell receptor and chain genes [4]. In our case the
blastsexpressedCD99,whichwasreportedasthemostuseful
antigen to indicate the precursor nature of T lymphoblasts
[5]. CD99 is intensely expressed in the earliest maturationalCase Reports in Hematology 3
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Figure 2: Blasts are shown in blue, lymphocytes in violet. Blasts are CD34+/−CD7+HLA−DR+CD38+CD99+CD3−cyCD3−
CD19−CD20−.
stages of the myeloid and the lymphoid lineages. Dworzak
et al. speculated that normal and leukemic cells could be
distinguishedinbonemarrowandperipheralbloodbasedon
CD99,sincematuration-relatedCD99overexpressionshould
be nonexistent or extremely rare on T cells outside the thy-
mus [5]. Considering that normal bone marrow and/or early
thymic cells are CD34+CD7+cyCD3− and are able to differ-
entiate into myeloid and lymphoid cells [6, 7], the expression
of CD7 and CD99 together on blasts negative for cyCD3
might be indicative of an earlier T-ALL than that of pro-
T-ALL. To support this hypothesis, Kawamoto et al. pro-
posed a new model of hemopoiesis where, a common myeloid-
lymphoid precursor was recognized [8]. Cytogenetic and mo-
lecular studies could be helpful in conjunction with immu-
nophenotype to conﬁrm the T lineage of such leukemia.
In this regard, our patient showed a TCR delta gene4 Case Reports in Hematology
rearrangement. As reported in literature, CD7+ early T-
cell acute lymphoblastic leukemia (T-ALL) shows a delta
gene rearrangement, which occurs earlier than expression
of cyCD3 epsilon protein products [9, 10]. Kimura et al.
observed that DDJ delta rearrangements have never been
observed in non-T-cell malignancies, such as precursor-
B-ALL or acute myeloid leukemia [10]. Thus, TCR delta
gene rearrangements studies represent a useful tool to es-
tablish lineage and clonality of leukemic cells in the most
immature stages of T-cell development [10]. While anecdo-
tal experience generally considers AUL to have a poor prog-
nosis, information is too scanty to make any deﬁnitive state-
ments about clinical features or outcome. T-ALL often
presents with a large mediastinal mass or other tissue mass.
Lymphadenopathy and hepatosplenomegaly are common.
Our patient presented at diagnosis with lymphadenopathy
and splenomegaly. Patients with ALL should have a lumbar
puncture to exclude or conﬁrm an involvement of the CNS
with leukemia. All treatment protocols for ALL include a
prophylaxis to the CNS by administrating drugs (e.g., me-
thotrexate) to the intrathecal space [11]. Our patient did
not have CNS involvement but achieved complete remission
following an ALL type treatment, thus supporting our diag-
nostic hypothesis. In conclusion, the immunophenotypic
study of a large number of T-ALL cases, in conjunction with
associated clinical features, cytogenetic and molecular stud-
ies, would be helpful in diﬀerential diagnosis with AUL
and might contribute to the choice of the most appropriate
treatment and management for these patients.
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